Bittersweet China
14/09/23 -"China has been and will be a growth market, and also when it comes to medtech. On the other hand, the Chinese government aims to root out deep-seated corruption. We have a strong belief that ..."
Pages
67
Language
English
Published on
14/09/23
You may also be interested by these reports :
29/09/23
After a terrible 2022, the situation for MedTechs seemed to be getting better. However, worries again took over, with the sector down c.6% (in ytd ...
25/09/23
We trim our FY23/24 estimates further by a double-digit / low single-digit, respectively, on account of the increasing question marks on the ...
25/09/23
The last time we teased on Sartorius, we believed this high quality bioprocessing asset was still rather expensive even after the 25% drop from its ...
22/09/23
Based on our recent discussion with the Carl Zeiss Meditec, it appears that earnings challenges are set to intensify in the near term due to – ...